Eton Pharmaceuticals, Inc. (ETON) Financial Statements (2024 and earlier)

Company Profile

Business Address 21925 W. FIELD PARKWAY
DEER PARK, IL 60010-7278
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments16,30514,40621,29512,06626,735
Cash and cash equivalents16,30514,40621,29512,06626,735
Receivables1,8525,47148473 
Inventory, net of allowances, customer advances and progress billings5575501,242380 
Inventory5575501,242380 
Prepaid expense     767
Other undisclosed current assets1,2903,1772,1162,090 
Total current assets:20,00423,60424,70115,00927,502
Noncurrent Assets
Operating lease, right-of-use asset188104192160
Property, plant and equipment721158111,117773
Intangible assets, net (including goodwill)4,7543,621575725 
Intangible assets, net (excluding goodwill)4,7543,621575725 
Other noncurrent assets1221406152
Total noncurrent assets:5,0263,8611,6182,063825
TOTAL ASSETS:25,03027,46526,31917,07228,327
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5,4283,1403,5141,9632,024
Accounts payable1,7661,7742,3445751,421
Accrued liabilities3,6621,3661,1701,388603
Debt1,0331,418   
Other undisclosed current liabilities   280  
Total current liabilities:6,4614,5583,7941,9632,024
Noncurrent Liabilities
Long-term debt and lease obligation:  159919 
Liabilities, other than long-term debt107    
Operating lease, liability107159919
Other undisclosed noncurrent liabilities5,3845,2476,6644,540 
Total noncurrent liabilities:5,4915,2776,8624,559 
Total liabilities:11,9529,83510,6566,5222,024
Equity
Equity, attributable to parent13,07817,63015,66310,55026,303
Common stock2525241818
Additional paid in capital116,187111,718107,79774,72072,153
Accumulated deficit(103,134)(94,113)(92,158)(64,188)(45,868)
Total equity:13,07817,63015,66310,55026,303
TOTAL LIABILITIES AND EQUITY:25,03027,46526,31917,07228,327

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues21,25121,83239959 
Cost of revenue
(Cost of Goods and Services Sold)
(6,933)(1,414)(286)(453) 
Other undisclosed gross profit  (1,209)   
Gross profit:14,31819,209(247)506 
Operating expenses(22,578)(20,704)(26,864)(19,107)(10,321)
Operating income (loss):(8,260)(1,495)(27,111)(18,601)(10,321)
Nonoperating income (expense)(761)(1,006)(859)  
Other nonoperating income     
Interest and debt expense(955)365(884)  
Income (loss) from continuing operations before equity method investments, income taxes:(9,976)(2,136)(28,854)(18,601)(10,321)
Other undisclosed income (loss) from continuing operations before income taxes955181884281(2,419)
Income (loss) from continuing operations before income taxes:(9,021)(1,955)(27,970)(18,320)(12,740)
Income tax expense     (2,579)
Income (loss) from continuing operations:(9,021)(1,955)(27,970)(18,320)(15,319)
Loss before gain (loss) on sale of properties:(1,955)(27,970)(18,320)(15,319)
Other undisclosed net income     2,579
Net income (loss) attributable to parent:(9,021)(1,955)(27,970)(18,320)(12,740)
Other undisclosed net loss available to common stockholders, basic     (24,489)
Net income (loss) available to common stockholders, diluted:(9,021)(1,955)(27,970)(18,320)(37,229)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net income (loss):(9,021)(1,955)(27,970)(18,320)(12,740)
Comprehensive income (loss), net of tax, attributable to parent:(9,021)(1,955)(27,970)(18,320)(12,740)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: